Search
for
Sort by
Research 61–90 of 1000+
- Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Effect of C-ring modifications in benzo[c]quinolizin-3-ones, new selective inhibitors of human 5α-reductase 1
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- A Role for Steroid 5 alpha-reductase 1 in Vascular Remodelling During Endometrial Decidualisation
- Novel inhibitors of 5α-reductase
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Causes of hair loss and the developments in hair rejuvenation
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
- In vitro and In vivo Effects of 17β-N-(4-phenylcarbamoyl) androst-4-en-3- one Derivatives as 5a-reductase Inhibitors on Androgen-dependent Glands
- Androgenetic alopecia; drug safety and therapeutic strategies
- Update on Frontal Fibrosing Alopecia
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Enabling finasteride 1 mg users to further improve hair pattern: A randomized, double-blind, placebo-controlled trial of a novel product
- Inhibitory Effects of Serenoa repens on the Kinetic of Pig Prostatic Microsomal 5α-Reductase Activity
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses
- A high-performance liquid chromatography–tandem mass spectrometry assay of the androgenic neurosteroid 3α-androstanediol (5α-androstane-3α,17β-diol) in plasma
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- 9 Role of 5α-reductase in health and disease
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Health Promotion Potential of Vegetables Cultivated in Northern Thailand: A Preliminary Screening of Tannin and Flavonoid Contents, 5α-Reductase Inhibition, Astringent Activity, and Antioxidant Activities
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- DHT and E2 synthesis-related proteins and receptors expression in male yak skin during different hair follicle stages
- Structure of human type II 5 alpha-reductase gene.
- The Safety and Efficacy of a Novel Saw Palmetto ( <i>Serenoa repens</i> ) Extract for Promoting Hair Growth in Adults With Self‐Perceived Thinning Hair: 180‐Day Results
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review